The Science
The Origin Story for MaculaPM™
Dr. McKay and Dr. Brilliant discuss the clinical research behind MaculaPM™, and in particular the protective role of L-DOPA in reducing the progression of wet AMD.
MaculaPM™ Ingredients
Proactive Eye Health for the Macula & Retina
L-DOPA
The key ingredient in MaculaPM™ has been shown in a clinical trial to slow the progression to Wet AMD.
Vitamin C
Vitamin C is an anti-oxidant that supports eye health that naturally reduces in concentration with age.
Vitamin E
Vitamin E is a potent anti-oxidant that supports eye health.
Melatonin
Melatonin has been shown to protect retinal pigment epithelium (RPE) cells from oxidative damage.
Lutein
Lutein works as an antioxidant that protects the eye from the effects of aging and ultraviolet light.
Zeaxanthin
Research shows that Zeaxanthin helps to reduce AMD progression and may improve visual acuity.
Meet the Medical Team Behind MaculaPM™
John A. Martens
With degrees in Chemical Engineering and Chemistry, John Martens has decades of experience as a scientist, engineer and product innovator. He served as a corporate scientist for 35 years at 3M Corporation, and he has been involved in the development of products and technologies for numerous nutraceutical, pharmaceutical and biomedical products related to the treatment of eye diseases.
Dr. Murray H. Brilliant
Dr. Brilliant has a degree in Biology and received his doctorate in Molecular Cell & Developmental Biology. He is currently a professor of Ophthalmology at the University of Arizona where he has a research focus in areas related to macular degeneration. Dr. Brilliant headed the research project that identified the profound protective benefits of L-DOPA on age-related macular degeneration.
Robert W. Snyder, MD, PhD, PC
Dr. Snyder has extensive clinical experience as well as a PhD in microbiology/cell biology. He has received peer reviewed funding for both clinical research and trials, as well as basic research. He served as the Chairman of Ophthalmology at The University of Arizona where he received numerous grants, clinical trials and NIH funding for research related to macular degeneration.
Dr. Brian McKay
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse sed bibendum turpis, eu congue sapien. Fusce non lacinia enim. In tristique laoreet ex, eu viverra lorem tristique vel. Cras lobortis viverra nisl quis porttitor.us natoque penatibus et magnis dison, auctor ligula. In hac habitasse platea dictumst.
About Tech Launch Arizona
The University of Arizona is a place of learning, invention and discovery. Tech Launch Arizona collaborates with creators and the local community to help bring those discoveries to the world through commercial pathways. The primary focus is ensuring that innovations originating with U of A faculty, researchers, staff and students find meaningful applications that benefit the public.
